GSK sold around 385 million shares at 324 pence apiece, amounting to a 4.2% stake in Haleon. The company was formed in a merger of GSK and Pfizer's consumer healthcare businesses in 2019. The sale was at a discount of about 2.5% to Haleon's last close of 332.4 pence on Thursday.
Everything you need to know about Championship play-off semi-final second-leg